| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | United States | 2 | |
| #3 | Australia | 1 | |
| #4 | Brazil | 1 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | EPO (European Patent Office) | 1 | |
| #8 | Israel | 1 | |
| #9 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Special acyclic compounds | |
| #5 | Specific use of cosmetics | |
| #6 | Sugars |
| # | Name | Total Patents |
|---|---|---|
| #1 | Shendelman Shoshana | 11 |
| #2 | Perfetti Riccardo | 1 |
| #3 | Shoshana Shendelman | 1 |
| #4 | Wasmuth Andrew | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021071965A1 | Aldose reductase inhibitors for treatment of phosphomannomutase 2 deficiency | |
| WO2020205846A1 | Inhibitors of aldose reductase | |
| WO2020167937A1 | Methods for treating cutaneous aging | |
| EP3658142A1 | Compositions and methods for treating galactosemia | |
| WO2018200258A1 | Aldose reductase inhibitors and uses thereof |